SERPINB12 as a possible marker of steroid dependency in children with eosinophilic esophagitis: A pilot study.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
02 2020
Historique:
received: 10 04 2019
revised: 22 06 2019
accepted: 15 08 2019
pubmed: 28 10 2019
medline: 16 12 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

Topical steroids are effective in eosinophilic esophagitis (EoE), but patients often show different tendencies to relapse. We assessed whether gene expression is associated with a sort of steroid dependency in EoE children. Biopsy samples were prospectively collected on EoE children responding to topical steroids. Patients treated with viscous budesonide for 24 weeks were subsequently classified as early (6 months) or late (>6 months) relapsing. RNA was isolated from esophageal biopsies at the time of the relapse and analyzed by NGS for transcriptome profiling. Of 40 patients, 22 patients were considered for mRNA expression profile. Thirteen were included in the early-relapse group, and 9 were in the late-relapse. No significant difference was observed in the two groups for clinical, endoscopic or histological features. Using the mRNA expression profile we performed supervised clustering using the 10 top differentially expressed genes between early and late relapsing patients. The heatmap and PCA show a proper segregation among patients. SERPINB12 is the only gene attaining a significant differential expression between the two groups (FDR < 0.05). Different tendencies to relapse in EoE children responding to topical steroids might be related to altered mRNA expressions. SERPINB12 presented a significantly higher expression in the late relapse group and it deserves further investigations.

Sections du résumé

BACKGROUND
Topical steroids are effective in eosinophilic esophagitis (EoE), but patients often show different tendencies to relapse. We assessed whether gene expression is associated with a sort of steroid dependency in EoE children.
METHODS
Biopsy samples were prospectively collected on EoE children responding to topical steroids. Patients treated with viscous budesonide for 24 weeks were subsequently classified as early (6 months) or late (>6 months) relapsing. RNA was isolated from esophageal biopsies at the time of the relapse and analyzed by NGS for transcriptome profiling.
RESULTS
Of 40 patients, 22 patients were considered for mRNA expression profile. Thirteen were included in the early-relapse group, and 9 were in the late-relapse. No significant difference was observed in the two groups for clinical, endoscopic or histological features. Using the mRNA expression profile we performed supervised clustering using the 10 top differentially expressed genes between early and late relapsing patients. The heatmap and PCA show a proper segregation among patients. SERPINB12 is the only gene attaining a significant differential expression between the two groups (FDR < 0.05).
CONCLUSIONS
Different tendencies to relapse in EoE children responding to topical steroids might be related to altered mRNA expressions. SERPINB12 presented a significantly higher expression in the late relapse group and it deserves further investigations.

Identifiants

pubmed: 31653522
pii: S1590-8658(19)30781-9
doi: 10.1016/j.dld.2019.08.018
pii:
doi:

Substances chimiques

Biomarkers 0
RNA, Messenger 0
SERPINB12 protein, human 0
Serpins 0
Steroids 0
Budesonide 51333-22-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-163

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Salvatore Oliva (S)

Maternal and Child Health Department, Sapienza-University of Rome, Pediatric Gastroenterology and Liver Unit, Italy. Electronic address: salvatore.oliva@uniroma1.it.

Ilaria Laudadio (I)

Department of Molecular Medicine, Sapienza-University of Rome, Italy.

Valerio Fulci (V)

Department of Molecular Medicine, Sapienza-University of Rome, Italy.

Danilo Rossetti (D)

Maternal and Child Health Department, Sapienza-University of Rome, Pediatric Gastroenterology and Liver Unit, Italy.

Sara Isoldi (S)

Maternal and Child Health Department, Sapienza-University of Rome, Pediatric Gastroenterology and Liver Unit, Italy.

Laura Stronati (L)

Department of Molecular Medicine, Sapienza-University of Rome, Italy.

Claudia Carissimi (C)

Department of Molecular Medicine, Sapienza-University of Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH